esorubicin has been researched along with EHS Tumor in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Casazza, AM; Di Marco, A; Pratesi, G; Savi, G | 1 |
| Cummings, J; Kaye, SB; Kerr, DJ; More, I; Morrison, JG; Willmott, N | 1 |
2 other study(ies) available for esorubicin and EHS Tumor
| Article | Year |
|---|---|
Antitumor activity in mice of 4'-deoxydoxorubicin in comparison with doxorubicin.
Topics: Animals; Antineoplastic Agents; Dose-Response Relationship, Drug; Doxorubicin; Female; Leukemia, Experimental; Male; Mammary Neoplasms, Experimental; Melanoma; Mice; Mice, Inbred Strains; Neoplasms, Experimental; Sarcoma, Experimental | 1983 |
Comparative cardiotoxicity and antitumour activity of doxorubicin (adriamycin) and 4'-deoxydoxorubicin and the relationship to in vivo disposition and metabolism in the target tissues.
Topics: Animals; Antibiotics, Antineoplastic; Doxorubicin; Heart; Male; Myocardium; Rats; Rats, Inbred Strains; Sarcoma, Experimental; Structure-Activity Relationship | 1987 |